U., P., K., T., P., D., S., S., & N., C. (2017). Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective.
Chicago Style CitationU., Permsuwan, Thavorn K., Dilokthornsakul P., Saokaew S., and Chaiyakunapruk N. Cost-effectiveness of Insulin Detemir Versus Insulin Glargine for Thai Type 2 Diabetes From a Payer’s Perspective. 2017.
MLA CitationU., Permsuwan, et al. Cost-effectiveness of Insulin Detemir Versus Insulin Glargine for Thai Type 2 Diabetes From a Payer’s Perspective. 2017.
Warning: These citations may not always be 100% accurate.